These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12604046)

  • 21. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/α(v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells.
    Jin YJ; Park I; Hong IK; Byun HJ; Choi J; Kim YM; Lee H
    Cell Signal; 2011 Jan; 23(1):125-34. PubMed ID: 20816750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase.
    Kondo M; Asai T; Katanasaka Y; Sadzuka Y; Tsukada H; Ogino K; Taki T; Baba K; Oku N
    Int J Cancer; 2004 Jan; 108(2):301-6. PubMed ID: 14639619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo.
    Kluza E; Jacobs I; Hectors SJ; Mayo KH; Griffioen AW; Strijkers GJ; Nicolay K
    J Control Release; 2012 Mar; 158(2):207-14. PubMed ID: 22079810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manganese-induced integrin affinity maturation promotes recruitment of alpha V beta 3 integrin to focal adhesions in endothelial cells: evidence for a role of phosphatidylinositol 3-kinase and Src.
    Dormond O; Ponsonnet L; Hasmim M; Foletti A; Rüegg C
    Thromb Haemost; 2004 Jul; 92(1):151-61. PubMed ID: 15213856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
    Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
    Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting liposomes to tumor endothelial cells for neutron capture therapy.
    Koning GA; Fretz MM; Woroniecka U; Storm G; Krijger GC
    Appl Radiat Isot; 2004 Nov; 61(5):963-7. PubMed ID: 15308176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.
    Temming K; Schiffelers RM; Molema G; Kok RJ
    Drug Resist Updat; 2005 Dec; 8(6):381-402. PubMed ID: 16309948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells.
    Dai W; Yang T; Wang X; Wang J; Zhang X; Zhang Q
    J Drug Target; 2010 May; 18(4):254-63. PubMed ID: 19824864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
    Hölig P; Bach M; Völkel T; Nahde T; Hoffmann S; Müller R; Kontermann RE
    Protein Eng Des Sel; 2004 May; 17(5):433-41. PubMed ID: 15235124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects.
    Son HN; Nam JO; Kim S; Kim IS
    Biochim Biophys Acta; 2013 Oct; 1833(10):2378-88. PubMed ID: 23792174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of a protein that binds integrin αvβ3 outside the ligand binding site.
    Turaga RC; Yin L; Yang JJ; Lee H; Ivanov I; Yan C; Yang H; Grossniklaus HE; Wang S; Ma C; Sun L; Liu ZR
    Nat Commun; 2016 May; 7():11675. PubMed ID: 27241473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional inhibition of NF-kappaB signal transduction in alphavbeta3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IkappaB gene.
    Ogawara K; Kułdo JM; Oosterhuis K; Kroesen BJ; Rots MG; Trautwein C; Kimura T; Haisma HJ; Molema G
    Arthritis Res Ther; 2006; 8(1):R32. PubMed ID: 16803639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3.
    Murphy JF; Steele C; Belton O; Fitzgerald DJ
    Br J Haematol; 2003 Apr; 121(1):157-64. PubMed ID: 12670347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.